AMA Releases Additional CPT for Johnson & Johnson COVID Vaccine

Gloryanne Bryant, RHIA, CDIP, CCS, CCDS Covid-19 Leave a Comment

AMA Releases Additional CPT for Johnson & Johnson COVID Vaccine

The American Medical Association (AMA) released on January 19th, 2021 new CPT codes for the COVID vaccine administration and the vaccine by Johnson and Johnson, which is still pending approval by the FDA.  This COVID-19 vaccine was under development by Janssen Pharmaceutica, a division of Johnson & Johnson.

The new CPT codes are:

  • 91303    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5mL dosage, for intramuscular use
  • 0031A    Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5mL dosage, single dose

Go to the following link to read more: AMA announces update to COVID-19 vaccine CPT codes | American Medical Association (ama-assn.org)

Documentation and coding accuracy is always essential for ALL patient encounters.

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up For MRA Blog Updates!

Recent Posts